{"id":2297,"date":"2018-03-07T13:07:32","date_gmt":"2018-03-07T18:07:32","guid":{"rendered":"https:\/\/www.myositis.org\/?page_id=2297"},"modified":"2025-10-21T15:49:38","modified_gmt":"2025-10-21T19:49:38","slug":"clinical-drug-trials","status":"publish","type":"page","link":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/","title":{"rendered":"Clinical Drug Trials"},"content":{"rendered":"\n
\n
\n
Drug Name<\/strong><\/td><\/tr>
Eligible<\/td>Study sites<\/td>More information<\/td><\/tr>
ADI-001<\/strong> (not yet named)<\/td><\/tr>
Adults with IIM<\/td>Buffalo, NY<\/td>More details \u00bb<\/strong><\/a>
Adicet Therapeutics
716-845-3057
NCT06375993<\/td><\/tr>
Anifrolumab (JASMINE)<\/strong><\/td><\/tr>
Ages 18-75 with DM or PM<\/td>217 sites worldwide<\/td>More details \u00bb<\/strong><\/a>
AstraZeneca \u00bb<\/a>
877-240-9479
NCT06455449<\/td><\/tr>
AP01<\/strong> (not yet named)<\/td><\/tr>
Adults with myositis and progressive ILD<\/td>150+ sites worldwide<\/td>More details \u00bb<\/strong><\/a>
Avalyn Pharma \u00bb<\/a>
MISTPPFStudy@AvalynPharma.com<\/a>
NCT06329401<\/td><\/tr>
Brepocitinib<\/strong> (VALOR)<\/strong><\/td><\/tr>
Adults with DM
<\/td>		(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
Priovant
212-634-9743
NCT05437263<\/td><\/tr>
CABA-201<\/strong> (CAR T cell therapy)<\/strong><\/td><\/tr>
Ages 6-75 with DM, ASyS, IMNM<\/td>25 sites in the US and UK<\/td>More details \u00bb<\/strong><\/a>
Cabaletta Bio \u00bb<\/a>
NCT06154252<\/td><\/tr>
CD-19-Targeted<\/strong> (CAR T cell therapy)<\/strong><\/td><\/tr>
Adults with refractory DM, PM, IMNM<\/td>54 sites in US and Europe<\/td>More details \u00bb<\/a><\/strong>
Bristol Myers Squibb \u00bb<\/a>
855-907-3286
NCT05869955<\/td><\/tr>
Daxdilimab<\/strong><\/td><\/tr>
Adults with DM or ASyS<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
Amgen
866-479-6742
NCT05669014<\/td><\/tr>
Dazukibart<\/strong>
<\/td><\/tr>
Adults with active DM or PM<\/td>128 sites worldwide<\/td>More details \u00bb<\/strong><\/a>
Pfizer \u00bb<\/a>
800-718-1021
NCT05895786<\/td><\/tr>
Efgartigimod (ALKIVIA)<\/strong><\/td><\/tr>
Adults with IIM<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
argenx
857-350-4834
NCT05523167<\/td><\/tr>
Empasiprubart (Empacific)<\/strong><\/td><\/tr>
Adults with DM<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
argenx
857-350-4834
NCT06284954<\/td><\/tr>
GLPG3667<\/strong> (not yet named) <\/td><\/tr>
Adults with DM<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
Galapagos NV
321-534-2900
NCT05695950<\/td><\/tr>
Nintedanib<\/strong> (MINT)<\/strong><\/td><\/tr>
Adults with ILD and myositis<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
MINTcc@pitt.edu<\/a>
412-648-9989
NCT05799755<\/td><\/tr>
Nipocalimab (SPIREA)<\/strong><\/td><\/tr>
Adults with IIM<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
J&J Innovative Medicine
844-434-4210
NCT05379634<\/td><\/tr>
NKX019 (allogeneic CAR NK cells targeting CD19)<\/strong><\/td><\/tr>
Ages 18-65 with DM, IMNM, or ASyS<\/td>10 sites in US
<\/td>		More details \u00bb<\/strong><\/a>
Nkarta, Inc.
clinicaltrials@nkartatx.com<\/a>
NCT06733935<\/td><\/tr>
Rapcabtagene Autoleucel<\/strong> (CAR T cell therapy)<\/strong><\/td><\/tr>
Adults with DM, NM, ASyS<\/td>30 sites worldwide<\/td>More details \u00bb<\/strong><\/a>
Novartis<\/a>
1-888-669-6682
NCT06665256<\/td><\/tr>
RAY121<\/strong> (RAINBOW Trial)<\/strong><\/td><\/tr>
Ages 18-75 with DM or IMNM<\/td>67 sites worldwide<\/td>More details \u00bb<\/strong><\/a>
Chugai Pharmaceuticals Co., Ltd
clinical-trials@chugai-pharm.co.jp<\/a>
NCT06371417<\/td><\/tr>
Sirolimus<\/strong><\/td><\/tr>
Adults with inclusion body myositis (IBM)<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
913-945-9926
NCT04789070<\/td><\/tr>
Ulviprubart (ABC008)<\/strong><\/td><\/tr>
Adults with inclusion body myositis (IBM)<\/td>(currently not recruiting)<\/td>More details \u00bb<\/strong><\/a>
Abcuro\/Syneos
617-865-5079
NCT05721573<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Drug Name Eligible Study sites More information ADI-001 (not yet named) Adults with IIM Buffalo, NY More details \u00bbAdicet Therapeutics716-845-3057NCT06375993 Anifrolumab (JASMINE) Ages 18-75 with DM or PM 217 sites…<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":278,"menu_order":212,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-2297","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nClinical Drug Trials - The Myositis Association<\/title>\n<meta name=\"description\" content=\"Check out a table outlining the current clinical drug trials available, including eligibility, study sites and additional details.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Drug Trials - The Myositis Association\" \/>\n<meta property=\"og:description\" content=\"Check out a table outlining the current clinical drug trials available, including eligibility, study sites and additional details.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"The Myositis Association\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Myositis\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-21T19:49:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@themyositisassc\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/\",\"url\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/\",\"name\":\"Clinical Drug Trials - The Myositis Association\",\"isPartOf\":{\"@id\":\"https:\/\/www.myositis.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png\",\"datePublished\":\"2018-03-07T18:07:32+00:00\",\"dateModified\":\"2025-10-21T19:49:38+00:00\",\"description\":\"Check out a table outlining the current clinical drug trials available, including eligibility, study sites and additional details.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#primaryimage\",\"url\":\"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png\",\"contentUrl\":\"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png\",\"width\":216,\"height\":52,\"caption\":\"AstraZeneca\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.myositis.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research\",\"item\":\"https:\/\/www.myositis.org\/research\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Clinical Trials\",\"item\":\"https:\/\/www.myositis.org\/research\/clinical-trials\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Clinical Drug Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.myositis.org\/#website\",\"url\":\"https:\/\/www.myositis.org\/\",\"name\":\"The Myositis Association\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.myositis.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.myositis.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.myositis.org\/#organization\",\"name\":\"The Myositis Association\",\"url\":\"https:\/\/www.myositis.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.myositis.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.myositis.org\/wp-content\/uploads\/2017\/12\/site-icon.png\",\"contentUrl\":\"https:\/\/www.myositis.org\/wp-content\/uploads\/2017\/12\/site-icon.png\",\"width\":\"512\",\"height\":\"512\",\"caption\":\"The Myositis Association\"},\"image\":{\"@id\":\"https:\/\/www.myositis.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Myositis\/\",\"https:\/\/x.com\/themyositisassc\",\"https:\/\/www.youtube.com\/user\/MyositisAssociation\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Drug Trials - The Myositis Association","description":"Check out a table outlining the current clinical drug trials available, including eligibility, study sites and additional details.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Drug Trials - The Myositis Association","og_description":"Check out a table outlining the current clinical drug trials available, including eligibility, study sites and additional details.","og_url":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/","og_site_name":"The Myositis Association","article_publisher":"https:\/\/www.facebook.com\/Myositis\/","article_modified_time":"2025-10-21T19:49:38+00:00","og_image":[{"url":"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@themyositisassc","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/","url":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/","name":"Clinical Drug Trials - The Myositis Association","isPartOf":{"@id":"https:\/\/www.myositis.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#primaryimage"},"image":{"@id":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png","datePublished":"2018-03-07T18:07:32+00:00","dateModified":"2025-10-21T19:49:38+00:00","description":"Check out a table outlining the current clinical drug trials available, including eligibility, study sites and additional details.","breadcrumb":{"@id":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#primaryimage","url":"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png","contentUrl":"https:\/\/www.myositis.org\/wp-content\/uploads\/2024\/11\/AstraZeneca.png","width":216,"height":52,"caption":"AstraZeneca"},{"@type":"BreadcrumbList","@id":"https:\/\/www.myositis.org\/research\/clinical-trials\/clinical-drug-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.myositis.org\/"},{"@type":"ListItem","position":2,"name":"Research","item":"https:\/\/www.myositis.org\/research\/"},{"@type":"ListItem","position":3,"name":"Clinical Trials","item":"https:\/\/www.myositis.org\/research\/clinical-trials\/"},{"@type":"ListItem","position":4,"name":"Clinical Drug Trials"}]},{"@type":"WebSite","@id":"https:\/\/www.myositis.org\/#website","url":"https:\/\/www.myositis.org\/","name":"The Myositis Association","description":"","publisher":{"@id":"https:\/\/www.myositis.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.myositis.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.myositis.org\/#organization","name":"The Myositis Association","url":"https:\/\/www.myositis.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.myositis.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.myositis.org\/wp-content\/uploads\/2017\/12\/site-icon.png","contentUrl":"https:\/\/www.myositis.org\/wp-content\/uploads\/2017\/12\/site-icon.png","width":"512","height":"512","caption":"The Myositis Association"},"image":{"@id":"https:\/\/www.myositis.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Myositis\/","https:\/\/x.com\/themyositisassc","https:\/\/www.youtube.com\/user\/MyositisAssociation"]}]}},"_links":{"self":[{"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/pages\/2297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/comments?post=2297"}],"version-history":[{"count":3,"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/pages\/2297\/revisions"}],"predecessor-version":[{"id":28161,"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/pages\/2297\/revisions\/28161"}],"up":[{"embeddable":true,"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/pages\/278"}],"wp:attachment":[{"href":"https:\/\/www.myositis.org\/wp-json\/wp\/v2\/media?parent=2297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}